Regardless of these results (expected in 2016), Phase III trials will be designed to determine whether intranasal glutathione has a disease-modifying effect in PD
1C), strongly suggesting that Prk1 is a novel regulator of metal sensitivity
Katagiri M, Satoh A, Tsuji S, Shirasawa T (2012) Effects of astaxanthin-rich Haematococcus pluvialis extract on cognitive function: a randomised, double-blind, placebo-controlled study
If the patient may not be able to protect the airway, endotracheal intubation should be performed before transfer
A multicenter, randomized, double blind, placebo-controlled phase II study of PL 14736 enema in the treatment of mild-to-moderate ulcerative colitis
Orforglipron (Foundayo) New for 2026 The newest addition to the metabolic toolkit, this is a non-peptide oral medication recently approved by the FDA